Advanced Materials Synthesis and Supply

The contract seeks specialized materials development to support non-cryogenic tissue preservation technologies by synthesizing novel polymers, hydrogels, or small-molecule stabilizers guided by AI-driven design models. The work requires end-to-end responsibility including molecular design, laboratory-scale synthesis, rigorous quality control, and scalable production methods to ensure batch consistency and performance under physiological conditions. The materials must be optimized for stability, biocompatibility, and compatibility with existing tissue handling protocols, avoiding the need for extreme cold storage. This is a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a closing date of May 12, 2026. The performance location is Washington, and the NAICS code 325193 identifies the focus on other pharmaceutical and medicinal chemical manufacturing. Respondents are expected to demonstrate technical expertise in advanced material synthesis and validation, with an emphasis on translating AI-predicted candidates into reliably producible, high-purity materials suitable for biomedical applications. All deliverables must support the agency’s goal of enabling durable, affordable, and logistically feasible tissue preservation outside liquid nitrogen environments.